Loading clinical trials...
Loading clinical trials...
Development of a Screening Test for Endometrial Hyperplasia in an At Risk Cohort
The investigators hypothesize that endometrial thickness will be a significant predictor of endometrial hyperplasia in a postmenopausal female population with metabolic syndrome: diabetes and/or insulin resistance, hypertension, and obesity.
The objective is to identify the utility of ultrasound as a screening test for endometrial hyperplasia and cancer in an "at risk" cohort. Endometrial carcinoma is an understudied cancer. This study will provide benefit regardless of its outcome, because it will be the first prospectively designed screening trial in an asymptomatic population.
Age
45 - 75 years
Sex
FEMALE
Healthy Volunteers
Yes
Penn State Milton S. Hershey
Hershey, Pennsylvania, United States
Start Date
April 1, 2005
Primary Completion Date
September 1, 2009
Completion Date
September 1, 2009
Last Updated
January 19, 2015
36
ACTUAL participants
Ultrasound and Biopsy
PROCEDURE
Lead Sponsor
Milton S. Hershey Medical Center
Collaborators
NCT05903131
NCT07077876
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions